Cargando…
RUFY3 Predicts Poor Prognosis and Promotes Metastasis through Epithelial-mesenchymal Transition in Lung Adenocarcinoma
Background: RUFY3 (RUN and FYVE domain-containing protein 3) has been shown to participate in cell migration, membrane transportation, and cellular signaling and is dysregulated in several cancer processes. However, the role of RUFY3 in lung cancer remains unclear. In the present study, we aimed to...
Autores principales: | Men, Wanfu, Li, Wenya, Li, Yu, Zhao, Jungang, Qu, Xiaohan, Li, Peiwen, Gong, Shulei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6856751/ https://www.ncbi.nlm.nih.gov/pubmed/31772661 http://dx.doi.org/10.7150/jca.35072 |
Ejemplares similares
-
RFC3 induces epithelial-mesenchymal transition in lung adenocarcinoma cells through the Wnt/β-catenin pathway and possesses prognostic value in lung adenocarcinoma
por: Gong, Shulei, et al.
Publicado: (2019) -
SOX5 predicts poor prognosis in lung adenocarcinoma and promotes tumor metastasis through epithelial-mesenchymal transition
por: Chen, Xin, et al.
Publicado: (2017) -
RUFY3 promotes the progression of hepatocellular carcinoma through activating NF-κB-mediated epithelial-mesenchymal transition
por: Zhang, Yang, et al.
Publicado: (2021) -
RUFY3 and RUFY4 are ARL8 effectors that promote coupling of endolysosomes to dynein-dynactin
por: Keren-Kaplan, Tal, et al.
Publicado: (2022) -
RUFY3 interaction with FOXK1 promotes invasion and metastasis in colorectal cancer
por: Xie, Ruyi, et al.
Publicado: (2017)